Therapeutic potential of in utero mesenchymal stem cell (MSCs) transplantation in rat foetuses with spina bifida aperta

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 7, 2012, Pages 1606-1617

  Li, Hui ^a   Gao, Fei ^a   Ma, Lili ^a   Jiang, Junhong ^a   Miao, Jianing ^a   Jiang, Mingyu ^a   Fan, Yang ^a   Wang, Lili ^a   Wu, Di ^a   Liu, Bo ^a   Wang, Weilin ^a   Lui, Vincent Chi Hang ^b   Yuan, Zhengwei ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

In utero MSCs transplantation; Mesenchymal stem cell; Neural tube defects; Neuron regeneration; Neurotrophic factors; Prenatal treatment

Indexed keywords

RETINOIC ACID;

ANIMAL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DISEASE MODEL; FEMALE; FETUS; FLUORESCENT ANTIBODY TECHNIQUE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METHODOLOGY; MICROINJECTION; NICK END LABELING; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPINAL CORD; SPINAL DYSRAPHISM; WISTAR RAT;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; FETUS; FLUORESCENT ANTIBODY TECHNIQUE; IN SITU NICK-END LABELING; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICROINJECTIONS; PREGNANCY; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; SPINA BIFIDA CYSTICA; SPINAL CORD; TRETINOIN;

RATTUS;

EID: 84863090071     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2011.01470.x     Document Type: Article

References (46)

1. Danzer E, Ernst LM, Rintoul NE, et al. In utero meconium passage in fetuses and newborns with myelomeningocele. J Neurosurg Pediatr. 2009; 3: 141-6.
2. Zhu L, Ling H. National Neural Tube Defects Prevention Program in China. Food Nutr Bull. 2008; 29: S196-204.
3. Kohl T, Hering R, Heep A, et al. Percutaneous fetoscopic patch coverage of spina bifida aperta in the human-early clinical experience and potential. Foetal Diagn Ther. 2006; 21: 185-93.
4. Fichter MA, Dornseifer U, Henke J, et al. Foetal spina bifida repair-current trends and prospects of intrauterine neurosurgery. Foetal Diagn Ther. 2008; 23: 271-86.
5. Yuan Z, Cheng W, Hou A, et al. Constipation is associated with spina bifida occulta in children. Clin Gastroenterol Hepatol. 2008; 6: 1348-53.
6. ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 44, July 2003. (Replaces Committee Opinion Number 252, March 2001). Obstet Gynecol. 2003; 102: 203-13.
7. Hirose S, Farmer DL, Albanese CT. Foetal surgery for myelomeningocele. Curr Opin Obstet Gynecol. 2001; 13: 215-22.
8. Sutton LN. Foetal surgery for neural tube defects. Best Pract Res Clin Obstet Gynaecol. 2008; 22: 175-88.
9. Rintoul NE, Sutton LN, Hubbard AM, et al. A new look at myelomeningoceles: functional level, vertebral level, shunting, and the implications for foetal intervention. Pediatrics. 2002; 109: 409-13.
10. Muench MO, Barcena A. Stem cell transplantation in the fetus. Cancer Control. 2004; 11: 105-18.
11. Roybal JL, Santore MT, Flake AW. Stem cell and genetic therapies for the fetus. Semin Foetal Neonatal Med. 2010; 15: 6.
12. Merianos D, Heaton T, Flake AW. In utero hematopoietic stem cell transplantation: progress toward clinical application. Biol Blood Marrow Transplant. 2008; 14: 729-40.
13. Muench MO. In utero transplantation: baby steps towards an effective therapy. Bone Marrow Transplant. 2005; 35: 537-47.
14. Fauza DO, Jennings RW, Teng YD, et al. Neural stem cell delivery to the spinal cord in an ovine model of foetal surgery for spina bifida. Surgery. 2008; 144: 367-73.
15. Guan K, Li H, Fan Y, et al. Defective development of sensory neurons innervating the levator ani muscle in foetal rats with anorectal malformation. Birth Defects Res A Clin Mol Teratol. 2009; 85: 583-7.
16. Yuan ZW, Lui VC, Tam PK. Deficient motor innervation of the sphincter mechanism in foetal rats with anorectal malformation: a quantitative study by fluorogold retrograde tracing. J Pediatr Surg. 2003; 38: 1383-8.
17. Jia H, Zhang K, Zhang S, et al. Quantitative analysis of sacral parasympathetic nucleus innervating the rectum in rats with anorectal malformation. J Pediatr Surg. 2007; 42: 1544-8.
18. Karp JM, Leng Teo GS. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell. 2009; 4: 206-16.
19. Prockop DJ, Kota DJ, Bazhanov N, et al. Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs). J Cell Mol Med. 2010; 14: 2190-9.
20. Torrente Y, Polli E. Mesenchymal stem cell transplantation for neurodegenerative diseases. Cell Transplant. 2008; 17: 1103-13.
21. Brazelton TR, Rossi FM, Keshet GI, et al. From marrow to brain: expression of neuronal phenotypes in adult mice. Science. 2000; 290: 1775-9.
22. Chen X, Wang XD, Chen G, et al. Study of in vivo differentiation of rat bone marrow stromal cells into schwann cell-like cells. Microsurgery. 2006; 26: 111-5.
23. Hofstetter CP, Schwarz EJ, Hess D, et al. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci U S A. 2002; 99: 2199-204.
24. Pisati F, Bossolasco P, Meregalli M, et al. Induction of neurotrophin expression via human adult mesenchymal stem cells: implication for cell therapy in neurodegenerative diseases. Cell Transplant. 2007; 16: 41-55.
25. Blaas HG, Eik-Nes SH. Sonoembryology and early prenatal diagnosis of neural anomalies. Prenat Diagn. 2009; 29: 312-25.
26. Watanabe M, Jo J, Radu A, et al. A tissue engineering approach for prenatal closure of myelomeningocele with gelatin sponges incorporating basic fibroblast growth factor. Tissue Eng Part A. 2010; 16: 1645-55.
27. Danzer E, Schwarz U, Wehrli S, et al. Retinoic acid induced myelomeningocele in foetal rats: characterization by histopathological analysis and magnetic resonance imaging. Exp Neurol. 2005; 194: 467-75.
28. Cipriani P, Guiducci S, Miniati I, et al. Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis. Arthritis Rheum. 2007; 56: 1994-2004.
29. Sanchez-Ramos J, Song S, Cardozo-Pelaez F, et al. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol. 2000; 164: 247-56.
30. Barile L, Cerisoli F, Frati G, et al. Bone marrow-derived cells can acquire cardiac stem cells properties in damaged heart. J Cell Mol Med. 2011; 15: 63-71.
31. Nakamura M, Bregman BS. Differences in neurotrophic factor gene expression profiles between neonate and adult rat spinal cord after injury. Exp Neurol. 2001; 169: 407-15.
32. Cecconi F, Piacentini M, Fimia GM. The involvement of cell death and survival in neural tube defects: a distinct role for apoptosis and autophagy?Cell Death Differ. 2008; 15: 1170-7.
33. Massa V, Savery D, Ybot-Gonzalez P, et al. Apoptosis is not required for mammalian neural tube closure. Proc Natl Acad Sci U S A. 2009; 106: 8233-8.
34. Pathak S, Lees C. Ultrasound structural foetal anomaly screening: an update. Arch Dis Child Foetal Neonatal Ed. 2009; 94: F384-90.
35. Romosan G, Henriksson E, Rylander A, et al. Diagnostic performance of routine ultrasound screening for foetal abnormalities in an unselected Swedish population in 2000-2005. Ultrasound Obstet Gynecol. 2009; 34: 526-33.
36. Farmer DL, von Koch CS, Peacock WJ, et al. In utero repair of myelomeningocele: experimental pathophysiology, initial clinical experience, and outcomes. Arch Surg. 2003; 138: 872-8.
37. Johnson MP, Sutton LN, Rintoul N, et al. Foetal myelomeningocele repair: short-term clinical outcomes. Am J Obstet Gynecol. 2003; 189: 482-7.
38. Zambelli H, Barini R, Iscaife A, et al. Successful developmental outcome in intrauterine myelomeningocele repair. Childs Nerv Syst. 2007; 23: 123-6.
39. Tulipan N, Sutton LN, Bruner JP, et al. The effect of intrauterine myelomeningocele repair on the incidence of shunt-dependent hydrocephalus. Pediatr Neurosurg. 2003; 38: 27-33.
40. Jendelova P, Herynek V, DeCroos J, et al. Imaging the fate of implanted bone marrow stromal cells labeled with superparamagnetic nanoparticles. Magn Reson Med. 2003; 50: 767-76.
41. Kopen GC, Prockop DJ, Phinney DG. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci U S A. 1999; 96: 10711-6.
42. Shyu WC, Chen CP, Lin SZ, et al. Efficient tracking of non-iron-labeled mesenchymal stem cells with serial MRI in chronic stroke rats. Stroke. 2007; 38: 367-74.
43. Rodrigues Hell RC, Silva Costa MM, Goes AM, et al. Local injection of BDNF producing mesenchymal stem cells increases neuronal survival and synaptic stability following ventral root avulsion. Neurobiol Dis. 2009; 33: 290-300.
44. Chen CJ, Ou YC, Liao SL, et al. Transplantation of bone marrow stromal cells for peripheral nerve repair. Exp Neurol. 2007; 204: 443-53.
45. Sadat S, Gehmert S, Song YH, et al. The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF. Biochem Biophys Res Commun. 2007; 363: 674-9.
46. Hirata Y, Meguro T, Kiuchi K. Differential effect of nerve growth factor on dopaminergic neurotoxin-induced apoptosis. J Neurochem. 2006; 99: 416-25.